Journey Medical Corporation to Present at the Emerging Growth Conference — Neutral

DERM  FBIO   GlobeNewsWire — August 18, 2025

SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Emerging Growth Conference on Wednesday, August 20, 2025 at 12:35 p.m. ET. All sessions will be conducted virtually through video webcasts.

image for news Journey Medical Corporation to Present at the Emerging Growth Conference

NEW YORK and TOKYO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Go IPO client, rYojbaba Co., Ltd. (“rYojbaba”), has successfully commenced trading under the symbol “RYOJ” on the Nasdaq Capital Market. HeartCore was compensated through an aggregate $500,000 in initial fees and warrants to acquire 3% of rYojbaba's common stock, on a fully diluted basis, which total up to approximately $1.35 million as of August 14, 2025.

image for news HeartCore's Go IPO Client, rYojbaba Co., Ltd., Begins Trading on the Nasdaq Stock Market

Avalo Therapeutics: Speculative Buy Ahead Of AVTX-009's LOTUS Results — Neutral

AVTX   Seeking Alpha — August 18, 2025

Avalo Therapeutics' value mostly hinges on AVTX-009. This is an IL-1β mAb in a Phase 2 LOTUS trial for hidradenitis suppurativa. This Phase 2 trial should give us topline results by mid-2026, which I consider its most significant near-term value driver at this point. AVTX-009 also seems to have higher affinity and half-life versus Lutikizumab, which could allow for fewer doses and stronger efficacy.

image for news Avalo Therapeutics: Speculative Buy Ahead Of AVTX-009's LOTUS Results

Record First Half at ICE Bonds for Corporate and Municipal Bond Trading — Neutral

ICE   Business Wire — August 18, 2025

ATLANTA & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange (NYSE: ICE), a leading global provider of technology and data, today announced record trading volume in the first half of 2025 for corporate bond and municipal bond trading on the ICE Bonds' electronic execution platforms. Trading on ICE Bonds reached record notional volume of $120 billion for corporate bonds in the first half of 2025, up 20% from the first half of 2024. Municipal bond trading reached record notional volume of $109.

image for news Record First Half at ICE Bonds for Corporate and Municipal Bond Trading

COLORADO SPRINGS, Colo., Aug. 18, 2025 /PRNewswire/ -- Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) announced today that its Rocky Gap Casino, Resort & Golf ("Rocky Gap") received multiple first-place awards in Casino Player Magazine's Best of Gaming Awards 2025: Maryland.

image for news Century Casinos Announces Rocky Gap Casino, Resort & Golf Honored with Multiple Accolades in Casino Player Magazine's 'Best of Gaming Awards 2025: Maryland'

SALINAS, Calif.--(BUSINESS WIRE)---- $ACHR #Archer--Archer Aviation (NYSE: ACHR) today announced that its Midnight aircraft successfully completed its longest piloted flight to date, flying approximately 55 miles in 31 minutes at speeds exceeding 126 mph. The flight took place at Archer's flight test facility in Salinas, California, in front of United Airlines' Chief Financial Officer, Mike Leskinen, who led United Airlines' early investment in Archer. Test flights in the preceding week reached speeds of nearly.

image for news Archer Completes 55 Mile Flight—Longest Yet For Piloted Midnight Aircraft

SINGAPORE--(BUSINESS WIRE)--Vantage Corp (NYSE American: VNTG) (“Vantage” or the “Company”), a shipbroking company providing comprehensive services including brokerage, consultancy, and operational support in the tanker market, announced that its wholly-owned subsidiary, Vantage (BVI) Corporation, has signed two additional non-binding Letters of Intent (LOI) to acquire a Hong Kong and Mainland China-based firm specializing in shipbroking and maritime services. Following the recently announced p.

image for news Vantage Corp Further Expands Asia-Pacific Presence with Two Additional LOIs to Acquire a Hong Kong and Mainland China-Based Shipbroking Firm

Premier, Inc. Declares Quarterly Cash Dividend — Neutral

PINC   Business Wire — August 18, 2025

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2025, to stockholders of record as of the close of business on September 1, 2025. About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement com.

image for news Premier, Inc. Declares Quarterly Cash Dividend

Apeiro will expand Ondas' capabilities into ground robotics and add fiber optic components for radio-independent UAV and UGV communications Through mature platforms, strategic customer relationships, and an expected $12 million in 2025 revenues, Apeiro will accelerate operating scale and commercial reach Acquisition demonstrates Ondas' commitment to leveraging its global operating platform to deliver a portfolio of advanced, AI-enabled capabilities to critical defense and security customers Transaction is expected to close in the third quarter of 2025 BOSTON, MA / ACCESS Newswire / August 18, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of private industrial …

image for news Ondas Enters into Definitive Agreement to Strengthen Multi-Domain Autonomy Leadership with Strategic Acquisition of Robotics Innovator Apeiro Motion

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, reports that its broad-spectrum antiviral drug NV-387 could help reduce resurgence of metastatic cancer caused by awakening of "sleeping" cancer cells due to viral infections. NV-387 has successfully completed a Phase I clinical trial and is being advanced into Phase II clinical trials.

image for news A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials

ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new Chief Financial Officer as the Company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization.

image for news Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy

Conference Call to Discuss Previously Announced Transaction and Workhorse's Second Quarter 2025 Financial Results Shareholders Can Submit Questions by Emailing [email protected] CINCINNATI and FOSTER CITY, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or the “Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, and Motiv Electric Trucks (“Motiv”), a leading manufacturer of medium-duty electric trucks and buses, remind shareholders that the companies will hold a conference call tomorrow morning, Tuesday, August 19, at 10:00 a.m.

image for news Workhorse Group and Motiv Electric Trucks Remind Shareholders to Submit Questions for Joint Conference Call on Tuesday, August 19, 2025 at 10:00 a.m. ET

MURRAY, Utah--(BUSINESS WIRE)--Beyond, Inc. renaming to Bed, Bath & Beyond and changing ticker symbol to BBBY.

image for news Beyond, Inc. Changes Name to Bed Bath & Beyond, Inc. and Reclaims Ticker Symbol BBBY

HUYA: Revenue Beat And Sustained Profitability Are Key Positives — Positive

HUYA   Seeking Alpha — August 18, 2025

I stick to a buy for HUYA after analyzing its latest quarterly performance. HUYA's Q2 topline surpassed expectations, thanks to a 34.2% YoY surge in game-related sales. The firm was also profitable on a non-GAAP basis in Q2 '25, representing the 6th consecutive quarter this feat has been achieved.

image for news HUYA: Revenue Beat And Sustained Profitability Are Key Positives

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold market analysis for August 18 - key intra-day price entry levels for active traders

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

image for news Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.

image for news Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CNC

Next-Gen Defense: 3 Stocks Riding the New Global Arms Race — Negative

KTOS  LHX  TDG   MarketBeat — August 18, 2025

Global military expenditure climbed by nearly 10% between 2023 and 2024, reaching $2.7 trillion last year as spending accelerated faster since the Cold War. Ongoing conflicts throughout Eastern Europe and the Middle East threaten to continue driving a worldwide race toward defense growth into the foreseeable future.

image for news Next-Gen Defense: 3 Stocks Riding the New Global Arms Race

Gold price modestly up as trader focus turns to major Fed event — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Kitco — August 18, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold price modestly up as trader focus turns to major Fed event

KGC Stock Zooms 70% in 6 Months: Should You Buy the Stock Now? — Positive

KGC   Zacks Investment Research — August 18, 2025

Kinross Gold has surged 70% in six months, fueled by strong earnings, high gold prices, and project execution.

image for news KGC Stock Zooms 70% in 6 Months: Should You Buy the Stock Now?